Evidence map›Paper›PMID 29777037›Full record

ArticleJournal of cell science2018

Inhibition of TBC1D5 activates Rab7a and can enhance the function of the retromer cargo-selective complex.

Matthew N J Seaman, Aamir S Mukadam, Sophia Y Breusegem

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthew N J SeamanDepartment of Clinical Biochemistry, Cambridge Institute for Medical Research, University of Cambridge, Addenbrookes Biomedical Campus, Cambridge, CB2 0XY, UK mnjs100@cam.ac.uk syab2@cam.ac.uk.ORCID 0000-0001-9916-3245
Aamir S MukadamDepartment of Clinical Biochemistry, Cambridge Institute for Medical Research, University of Cambridge, Addenbrookes Biomedical Campus, Cambridge, CB2 0XY, UK.
Sophia Y BreusegemDepartment of Clinical Biochemistry, Cambridge Institute for Medical Research, University of Cambridge, Addenbrookes Biomedical Campus, Cambridge, CB2 0XY, UK mnjs100@cam.ac.uk syab2@cam.ac.uk.
University of Cambridge · GB

Funding

Medical Research Council MR/L007533/1Wellcome Trust
6 · The paper itself

Abstract

The retromer complex is a vital component of the endosomal protein sorting machinery necessary for sorting into both the endosome-to-Golgi retrieval pathway and also the endosome-to-cell-surface recycling pathway. Retromer mediates cargo selection through a trimeric complex comprising VPS35, VPS29 and VPS26, which is recruited to endosomes by binding to Rab7a and Snx3. Retromer function is linked to two distinct neurodegenerative diseases, Parkinson's disease and Alzheimer's disease and modulating retromer function has been proposed as an avenue to explore for a putative therapy in these conditions. We hypothesised that activating Rab7a to promote the recruitment of retromer to endosomes could positively modulate its activity. Here, we show that inhibition of the GTPase activating protein TBC1D5 can enhance Rab7a activation and lead to a gain of function for retromer.

Indexed as

GTPase-Activating ProteinsHumansProtein Transportrab7 GTP-Binding Proteinsrab GTP-Binding ProteinsGTPase-Activating Proteinsrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, humanrab GTP-Binding ProteinsTBC1D5 protein, humanActivationEndosomeRab7RetromerSortingTBC1D5

Identifiers

PMID29777037
PMCPMC6031384
OpenAlexW2803782032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.